The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression
Open accessAbstract
Keap1 is a negative regulator of Nrf2, a bZIP transcription factor that mediates adaptation to oxidative stress. Previous studies suggested this negative regulation is a consequence of Keap1 controlling the subcellular distribution of Nrf2. We now report that Keap1 also controls the total cellular level of Nrf2 protein. In the RL34 non-transformed rat liver cell line, Nrf2 was found to accumulate rapidly in response to oxidative stress caused by treatment with sulforaphane, and the accumulation resulted from inhibition of proteasomal-mediated degradation of the bZIP protein. By heterologously expressing in COS1 cells epitope-tagged Nrf2 and an Nrf2DeltaETGE mutant lacking the Keap1-binding site, in both the presence and absence of Keap1 we demonstrate that Nrf2 is subject to ubiquitination and proteasomal degradation independently of both Keap1 and the redox environment of the cell. In oxidatively stressed cells, this is the sole mechanism responsible for Nrf2 degradation. However, under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1. Within Nrf2, the N-terminal Neh2 domain is identified as the redox-sensitive degron. These data suggest that Keap1 negatively regulates Nrf2 by both enhancing its rate of proteasomal degradation and altering its subcellular distribution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteasomal degradation [50,51,52].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [52]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,296
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationDinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Hayes, J. D., & McLellan, L. I. (1999) · Free Radical Research · doi:10.1080/10715769900300851 · Cited by 1,528
The Proteasome: Paradigm of a Self-Compartmentalizing Protease
Baumeister, W. P., Walz, J., Zühl, F., & Seemüller, E. (1998) · Cell · doi:10.1016/s0092-8674(00)80929-0 · Cited by 1,497
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,473
The ubiquitin–proteasome pathway: on protein death and cell life
Ciechanover, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,419
Flagged first, then by citations
Research works printed but not linked: 4
- Kelly, 2000, Cancer Res., 60, 957
- McMahon, 2001, Cancer Res., 61, 3299
- Thimmulappa, 2002, Cancer Res., 62, 5196
- Bonneson, 2001, Cancer Res., 61, 6120
Cited by
Sorted by citations
Items 101–200 of 1,000
The Role of Nrf2 in Cardiovascular Function and Disease
Satta, S., Mahmoud, A. M., Wilkinson, F. L., Alexander, M. Y., & White, S. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9237263 · Cited by 306
Suzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Nasuhara, Y., Kaga, K., Kondo, S., & Nishimura, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0424oc · Cited by 286
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Gan, L., & Johnson, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.011 · Cited by 288
Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J. D., & Yamamoto, M. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8044-8051.2005 · Cited by 289
Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
Aleksunes, L. M., & Manautou, J. E. (2007) · Toxicologic Pathology · doi:10.1080/01926230701311344 · Cited by 288
Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J., & Davies, K. J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277145 · Cited by 284
Gao, L., Wang, J., Sekhar, K. R., Yin, H., Yared, N. F., Schneider, S. N., Sasi, S., Dalton, T. P., Anderson, M. E., Chan, J. Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607622200 · Cited by 289
Bai, Y., Cui, W., Xin, Y., Miao, X., Barati, M. T., Zhang, C., Chen, Q., Tan, Y., Cui, T., Zheng, Y., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.008 · Cited by 274
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274
Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273
Chen, C., & Kong, A. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.004 · Cited by 269
Chen, C., Pung, D., Leong, V., Hebbar, V., Shen, G., Nair, S., Li, W., & Kong, A.-N. T. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.021 · Cited by 260
Update on the Kelch-like (KLHL) gene family
Dhanoa, B. S., Cogliati, T., Satish, A. G., Bruford, E. A., & Friedman, J. S. (2013) · Human Genomics · doi:10.1186/1479-7364-7-13 · Cited by 260
Rushworth, S. A., Zaitseva, L., Murray, M. Y., Shah, N. M., Bowles, K. M., & MacEwan, D. J. (2012) · Blood · doi:10.1182/blood-2012-04-422121 · Cited by 290
NRF2, a Superstar of Ferroptosis
Yan, R., Lin, B., Jin, W., Tang, L., Hu, S., & Cai, R. (2023) · Antioxidants · doi:10.3390/antiox12091739 · Cited by 292
Giudice, A., Arra, C., & Turco, M. C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_3 · Cited by 254
Thirty years of NRF2: advances and therapeutic challenges.
Zhang, D. D. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01145-0 · Cited by 282
Ishii, Y., Itoh, K., Morishima, Y., Kimura, T., Kiwamoto, T., IIzuka, T., Hegab, A. E., Hosoya, T., Nomura, A., Sakamoto, T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6968 · Cited by 248
Regulation of Nrf2 signaling and longevity in naturally long-lived rodents
Lewis, K. N., Wason, E., Edrey, Y. H., Kristan, D. M., Nevo, E., & Buffenstein, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417566112 · Cited by 249
Li, L., Dong, H., Song, E., Xu, X., Liu, L., & Song, Y. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.12.005 · Cited by 246
Nrf2: a dark horse in Alzheimer's disease treatment
Osama, A., Zhang, J., Yao, J., Yao, X., & Fang, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101206 · Cited by 264
Nrf2 affects the efficiency of mitochondrial fatty acid oxidation
Ludtmann, M. H. R., Angelova, P. R., Zhang, Y., Abramov, A. Y., & Dinkova‐Kostova, A. T. (2013) · Biochemical Journal · doi:10.1042/bj20130863 · Cited by 241
Rojo, A. I., de Sagarra, M. R., & Cuadrado, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05124.x · Cited by 246
Dietary chemopreventive compounds and ARE/EpRE signaling
Chen, C., & Kong, A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.015 · Cited by 241
Nrf2 protects against airway disorders
Cho, H., & Kleeberger, S. R. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.024 · Cited by 238
Bulatov, E., & Ciulli, A. (2015) · Biochemical Journal · doi:10.1042/bj20141450 · Cited by 237
Protein Damage by Reactive Electrophiles: Targets and Consequences
Liebler, D. C. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700235t · Cited by 235
Velichkova, M., & Hasson, T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4501-4513.2005 · Cited by 243
Crystal Structure of Quinone Reductase 2 in Complex with Resveratrol ,
Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T., WU, J. M., & Zhang, Z. (2004) · Biochemistry · doi:10.1021/bi049162o · Cited by 242
Hourihan, J. M., Kenna, J. G., & Hayes, J. D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4944 · Cited by 239
Activation of the Nrf2–ARE signaling pathway: a promising strategy in cancer prevention
Giudice, A., & Montella, M. (2006) · BioEssays · doi:10.1002/bies.20359 · Cited by 232
A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway
Zhang, Y., & Gordon, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.885.3.7 · Cited by 231
Dinkova‐Kostova, A. T., Jenkins, S. N., Fahey, J. W., Ye, L., Wehage, S. L., Liby, K. T., Stephenson, K. K., Wade, K. L., & Talalay, P. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.09.012 · Cited by 230
Meakin, P. J., Chowdhry, S., Sharma, R. S., Ashford, F. B., Walsh, S. V., McCrimmon, R. J., Dinkova‐Kostova, A. T., Dillon, J. F., Hayes, J. D., & Ashford, M. L. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00677-14 · Cited by 233
Li, J., Johnson, D. A., Calkins, M. J., Wright, L. S., Svendsen, C. N., & Johnson, J. A. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi027 · Cited by 229
Dreger, H., Westphal, K., Weller, A., Baumann, G., Stangl, V., Meiners, S., & Stangl, K. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp107 · Cited by 226
Reactive Oxygen Production Induced by the Gut Microbiota: Pharmacotherapeutic Implications
Jones, R. M., Mercante, J. W., & Neish, A. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799828283 · Cited by 232
Kim, J.-E., You, D., Lee, C., Ahn, C., Seong, J. Y., & Hwang, J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.06.004 · Cited by 234
Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury
Kim, E. N., Lim, J. H., Kim, M. Y., Ban, T. H., Jang, I.-A., Yoon, H. E., Park, C. W., Chang, Y. S., & Choi, B. S. (2018) · Aging · doi:10.18632/aging.101361 · Cited by 222
Pajares, M., Rojo, A. I., Arias, E., Díaz-Carretero, A., Cuervo, A. M., & Cuadrado, A. (2018) · Autophagy · doi:10.1080/15548627.2018.1474992 · Cited by 218
Ryoo, I.-G., & Kwak, M. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.014 · Cited by 230
Dinkova‐Kostova, A. T., Holtzclaw, W. D., & Wakabayashi, N. (2005) · Biochemistry · doi:10.1021/bi047434h · Cited by 220
A systems biology perspective on Nrf2-mediated antioxidant response
Zhang, Q., Pi, J., Woods, C. G., & Andersen, M. E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.018 · Cited by 223
McWalter, G. K., Higgins, L. G., McLellan, L. I., Henderson, C. J., Hayes, J. D., Song, L., Thornalley, P. J., Itoh, K., & Yamamoto, M. P. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3499s · Cited by 214
Higgins, L. G., & Hayes, J. D. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.567391 · Cited by 217
Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression
Bellezza, I., Mierla, A. L., & Minelli, A. (2010) · Cancers · doi:10.3390/cancers2020483 · Cited by 220
Rushworth, S. A., MacEwan, D. J., & O’Connell, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6730 · Cited by 215
Fruit-Derived Polyphenol Supplementation for Athlete Recovery and Performance
Bowtell, J., & Kelly, V. (2019) · Sports Medicine · doi:10.1007/s40279-018-0998-x · Cited by 213
Pi, J., Bai, Y., Reece, J. M., Williams, J. G., Liu, D., Freeman, M. L., Fahl, W. E., Shugar, D., Liu, J., Qu, W., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.001 · Cited by 217
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Katoh, Y., Iida, K., Kang, M.-I., Kobayashi, A., Mizukami, M., Tong, K. I., McMahon, M. J., Hayes, J. D., Itoh, K., & Yamamoto, M. P. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.10.012 · Cited by 217
Hannan, M. A., Dash, R., Sohag, A. A. M., Haque, M. N., & Moon, I. S. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00116 · Cited by 215
Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress
Mercado, N., Thimmulappa, R. K., Thomas, C. M. R., Fenwick, P. S., Chana, K. K., Donnelly, L., Biswal, S. S., Ito, K., & Barnes, P. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.035 · Cited by 216
Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
Achuthan, S., Santhoshkumar, T. R., Prabhakar, J., Nair, S. A., & Pillai, M. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200675 · Cited by 211
Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice
Goldring, C. E., Kitteringham, N. R., Elsby, R., Randle, L. E., Clement, Y. N., Williams, D. P., McMahon, M. J., Hayes, J. D., Itoh, K., Yamamoto, M. P., et al. (2004) · Hepatology · doi:10.1002/hep.20183 · Cited by 207
Walters, D. M., Cho, H., & Kleeberger, S. R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1901 · Cited by 205
An Auto-regulatory Loop between Stress Sensors INrf2 and Nrf2 Controls Their Cellular Abundance
Lee, O.-H., Jain, A. K., Papusha, V. Z., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706517200 · Cited by 205
KEAP1–NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity
Dodson, M. B., Redmann, M., Rajasekaran, N. S., Darley-Usmar, V. M., & Zhang, J. (2015) · Biochemical Journal · doi:10.1042/bj20150568 · Cited by 204
Oncogenic functions of the transcription factor Nrf2
Gañán‐Gómez, I., Wei, Y., Yang, H., Boyano-Adánez, M. C., & Garcia‐Manero, G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.041 · Cited by 203
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Bai, Y., Wang, X., Zhao, S., Ma, C., Cui, J., & Zheng, Y. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/407580 · Cited by 204
Nrf2 as a target for cancer chemoprevention
Yu, X. Y., & Kensler, T. W. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.04.017 · Cited by 199
Miller, V. J., Villamena, F. A., & Volek, J. S. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/5157645 · Cited by 205
Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke
Alfieri, A., Srivastava, S., Siow, R. C. M., Modo, M., Fraser, P. A., & Mann, G. E. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.210294 · Cited by 198
Nrf2: Molecular and epigenetic regulation during aging
Silva‐Palacios, A., Ostolga-Chavarría, M., Zazueta, C., & Königsberg, M. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.003 · Cited by 199
Human glutamate cysteine ligase gene regulation through the electrophile response element
Dickinson, D. A., Levonen, A., Moellering, D. R., Arnold, E. K., Zhang, H., Darley-Usmar, V. M., & Forman, H. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.011 · Cited by 201
Nitric Oxide in Cell Survival: A Janus Molecule
Calabrese, V., Cornelius, C., Rizzarelli, E., Owen, J. B., Dinkova‐Kostova, A. T., & Butterfield, D. A. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2721 · Cited by 198
Chapple, S., Cheng, X.-H., & Mann, G. (2013) · Redox Biology · doi:10.1016/j.redox.2013.04.001 · Cited by 183
Critical role of AMPK in redox regulation under glucose starvation
Ren, Y., & Shen, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101154 · Cited by 201
Regulation of Nrf2 Transactivation Domain Activity
Shen, G., Hebbar, V., Nair, S., Xu, C., Li, W., Lin, W., Keum, Y.-S., Han, J., Gallo, M. A., & Kong, A.-N. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401368200 · Cited by 194
Kahn, N., Rea, S. L., Moyle, S. S., Kell, A. M., & Johnson, T. (2008) · Biochemical Journal · doi:10.1042/bj20070521 · Cited by 192
NRF2 Activation in Cancer: From DNA to Protein
Cloer, E. W., Goldfarb, D., Schrank, T. P., Weissman, B. E., & Major, M. B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2723 · Cited by 182
Hayes, J. D., Chowdhry, S., Dinkova‐Kostova, A. T., & Sutherland, C. D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150011 · Cited by 187
Reisman, S. A., Aleksunes, L. M., & Klaassen, C. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.028 · Cited by 186
Negi, G., Kumar, A., & Sharma, S. S. (2011) · Current Neurovascular Research · doi:10.2174/156720211798120972 · Cited by 183
Cheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 182
A Review on Anti-Tumor Mechanisms of Coumarins
Wu, Y. P., Xu, J., Liu, Y., Zeng, Y., & Wu, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.592853 · Cited by 192
Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing enzymes
Nakamura, Y., Yoshida, C., Murakami, A., Ohigashi, H., Osawa, T., & Uchida, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.042 · Cited by 182
Mitogen-Activated Protein Kinases in Mammalian Oxidative Stress Responses
Runchel, C., Matsuzawa, A., & Ichijo, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3733 · Cited by 179
Higgins, L. G., Kelleher, M., Eggleston, I. M., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.005 · Cited by 178
Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases
Cominacini, L., Mozzini, C., Garbin, U., Pasini, A., Stranieri, C., Solani, E., Vallerio, P., Tinelli, I. A., & Pasini, A. F. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.027 · Cited by 180
Exercise-Stimulated ROS Sensitive Signaling Pathways in Skeletal Muscle
Bouvière, J., Fortunato, R. S., Dupuy, C., Werneck‐de‐Castro, J. P., de Carvalho, D. P., & Louzada, R. A. N. (2021) · Antioxidants · doi:10.3390/antiox10040537 · Cited by 184
Reisman, S. A., Yeager, R. L., Yamamoto, M. P., & Klaassen, C. D. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn267 · Cited by 174
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
Casares, L., García, V., Garrido‐Rodríguez, M., Millán, E., Collado, J. A., García‐Martín, A., Peñarando, J., Calzado, M. A., de la Vega, L., & Muñóz, E. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101321 · Cited by 181
Chemoprotection by sulforaphane: Keep one eye beyond Keap1
Myzak, M. C., & Dashwood, R. H. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.02.033 · Cited by 173
Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1089-1099.2005 · Cited by 173
Redox signaling: an evolution from free radicals to aging
Forman, H. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.003 · Cited by 172
The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?
Copple, I. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-398339-8.00002-1 · Cited by 174
Targeting the Nrf2 pathway against cardiovascular disease
Li, J., Ichikawa, T., Janicki, J. S., & Cui, T. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903025762 · Cited by 168
Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time
Fuse, Y., & Kobayashi, M. (2017) · Molecules · doi:10.3390/molecules22030436 · Cited by 175
Novel Chalcone Derivatives as Potent Nrf2 Activators in Mice and Human Lung Epithelial Cells
Kumar, V., Kumar, S., Hassan, M. A., Wu, H., Thimmulappa, R. K., Kumar, A., Sharma, S. K., Parmar, V. S., Biswal, S. S., & Malhotra, S. V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002348 · Cited by 168
Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges
Torrente, L., & DeNicola, G. M. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-104025 · Cited by 175
Redox regulation of gamma-glutamyl transpeptidase.
Zhang, H.-Q., & Forman, H. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0169tr · Cited by 140
Giuliani, M. E., & Regoli, F. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.03.003 · Cited by 166
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Tsuchida, K., Tsujita, T., Hayashi, M., Ojima, A., Keleku-Lukwete, N., Katsuoka, F., Otsuki, A., Kikuchi, H., Oshima, Y., Suzuki, M., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.041 · Cited by 165
Frank, R., Scheffler, M., Merkelbach‐Bruse, S., Ihle, M. A., Kron, A., Rauer, M., Ueckeroth, F., König, K., Michels, S. Y. F., Fischer, R. N., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3416 · Cited by 167
Yao, J., Zhang, B., Ge, C., Peng, S., & Fang, J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505075n · Cited by 166
Warabi, E., Takabe, W., Minami, T., Inoue, K., Itoh, K., Yamamoto, M. P., Ishii, T., Kodama, T., & Noguchi, N. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.10.043 · Cited by 165
Zhang, G., Zou, X., Huang, Y., Wang, F., Miao, S., Liu, G., Chen, M., & Zhu, Y. (2016) · Kidney & Blood Pressure Research · doi:10.1159/000443413 · Cited by 164
Jin, M., Wang, J., Ji, X., Cao, H., Zhu, J., Chen, Y., Jin, Y., Zhao, Z., Ren, T., & Xing, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1135-x · Cited by 163
Hirota, A., Kawachi, Y., Itoh, K., Nakamura, Y., Xu, X., Banno, T., Takahashi, T., Yamamoto, M. P., & Otsuka, F. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23670.x · Cited by 162
Metadata
- Authors
- McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D.
- Affiliations
- University of Dundee (GB)
- University of Tsukuba (JP)
- Corresponding author
- McMahon, Michael
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21592-21600
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040114786
- Cited by
- 1,141
- References
- 54
- Citations by year
- 2026: 39 · 2025: 52 · 2024: 56 · 2023: 53 · 2022: 54 · 2021: 57 · 2020: 66 · 2019: 56 · 2018: 52 · 2017: 67 · 2016: 65 · 2015: 47 · 2014: 60 · 2013: 50 · 2012: 45
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Keap1, Nrf2, proteasomal degradation, ubiquitination, oxidative stress, antioxidant response element, bZIP transcription factors, subcellular localization, sulforaphane, hepatocytes
- MeSH terms
- Animals, Epitopes, Antioxidants, Binding Sites, Carrier Proteins, Cell Line, Cell Nucleus, Cysteine Endopeptidases, DNA-Binding Proteins, Escherichia coli, Gene Expression Regulation, Multienzyme Complexes, Oxidation-Reduction, Plasmids, Protein Binding, RNA, Messenger, Subcellular Fractions, Sulfoxides, Thiocyanates, Time Factors, Transcription, Genetic, Transfection, Immunoblotting, Trans-Activators, Protein Structure, Tertiary, Isothiocyanates, Genes, Reporter, Oxidative Stress, COS Cells, Response Elements, Ubiquitin, Proteasome Endopeptidase Complex, NF-E2-Related Factor 2, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review